SP1 POLYPEPTIDES, MODIFIED SP1 POLYPEPTIDES AND USES THEREOF
The present invention relates to a composition of matter comprising an SP-1 polypeptide in reversible molecular association with a nanoparticle..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Europäisches Patentamt - (2019) vom: 23. Okt. Zur Gesamtaufnahme - year:2019 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
WOLF AMNON [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2019-10-23, Last update posted on www.tib.eu: 2022-09-17, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
EP2487182 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA013637452 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA013637452 | ||
| 003 | DE-627 | ||
| 005 | 20230503185138.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2019 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA013637452 | ||
| 035 | |a (EPA)EP2487182 | ||
| 035 | |a (EPA)37637586 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a WOLF AMNON |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SP1 POLYPEPTIDES, MODIFIED SP1 POLYPEPTIDES AND USES THEREOF |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2019-10-23, Last update posted on www.tib.eu: 2022-09-17, Last updated: 2023-02-09 | ||
| 520 | |a The present invention relates to a composition of matter comprising an SP-1 polypeptide in reversible molecular association with a nanoparticle. | ||
| 650 | 4 | |a C07H: Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids (derivatives of aldonic or saccharic acids c07c, c07d;aldonic acids, saccharic acids c07c0059105000, c07c0059285000;cyanohydrins c07c0255160000;glycals c07d;compounds of unknown constitution c07g;polysaccharides, derivatives thereof c08b;dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification c12n0015000000;sugar industry c13) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a B82Y: Specific uses or applications of nanostructures; measurement or analysis of nanostructures; manufacture or treatment of nanostructures | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a bio | |
| 650 | 4 | |a C12Q: Measuring or testing processes involving enzymes, nucleic acids or microorganisms (immunoassay g01n0033530000); compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes | |
| 650 | 4 | |a tec | |
| 650 | 4 | |a phy | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a POUNY YEHONATHAN |4 aut | |
| 700 | 0 | |a MARTON IRA |4 aut | |
| 700 | 0 | |a DGANY OR |4 aut | |
| 700 | 0 | |a ALTMAN ARIE |4 aut | |
| 700 | 0 | |a SHOSEYOV ODED |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2019) vom: 23. Okt. |
| 773 | 1 | 8 | |g year:2019 |g day:23 |g month:10 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/37637586/publication/EP2487182A1?q=EP2487182 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2019 |b 23 |c 10 |
| 951 | |a AR | ||
| 952 | |j 2019 |b 23 |c 10 | ||